New Developments and Insights in the Improvement of Mycobacterium tuberculosis Vaccines and Diagnostics Within the End TB Strategy
Author:
Funder
Ruth Chapman Cowles and Andrew G. Cowles Memorial Trust
Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation
Publisher
Springer Science and Business Media LLC
Subject
General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s40471-021-00269-2.pdf
Reference129 articles.
1. World Health Organization (WHO). Global Tuberculosis Report 2019: World Health Organization; 2019. [cited 2020 Aug 26]. Available from: https://www.who.int/tb/global-report-2019
2. Kyu HH, Maddison ER, Henry NJ, Mumford JE, Barber R, Shields C, et al. The global burden of tuberculosis: results from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2018;18(3):261–84 [cited 2018 Oct 5]. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29223583.
3. Tanimura T, Jaramillo E, Weil D, Raviglione M, Lönnroth K. Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review. Eur Respir J. 2014;43:1763–75 [cited 2020 Jul 10]. Available from: https://pubmed.ncbi.nlm.nih.gov/24525439/.
4. Ukwaja KN, Modebe O, Igwenyi C, Alobu I. The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int J Tuberc Lung Dis. 2012;16:733–9.
5. Walcott RL, Ingels JB, Corso PS, Zalwango S, Whalen CC, Sekandi JN. There’s no such thing as a free TB diagnosis: catastrophic TB costs in urban Uganda. Glob Public Health. 2020;15(6):877–88.
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain;Computational Biology and Chemistry;2023-06
2. Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors: State of Art Past 20 Years;BIOINTERFACE RES APP;2023
3. Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination;Vaccines;2022-12-12
4. Blue Skies research is essential for ending the Tuberculosis pandemic and advancing a personalized medicine approach for holistic management of Respiratory Tract infections.;International Journal of Infectious Diseases;2022-11
5. Tuberculosis Phenotypic and Genotypic Drug Susceptibility Testing and Immunodiagnostics: A Review;Frontiers in Immunology;2022-07-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3